Validation & QC · AI & data · Clinical flow · Industry
CFCM Daily Radar — Synthetic Controls, EuroFlow AI, NK Clonality and CDx
Synthetic myeloma controls lead today’s radar, alongside decade-scale EuroFlow AML computation, tissue-aware NK clonality, Waters–CellCarta companion-diagnostic strategy and ESCCA measurement uncertainty guidance.
Evidence boundary. Peer-reviewed studies, professional recommendations and company announcements are labelled separately. No regulatory approval is inferred from the Waters–CellCarta partnership.
CFCM report published 7 October 2026



